Your browser doesn't support javascript.
loading
Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B12 uptake route.
Bloch, Joël S; Sequeira, Jeffrey M; Ramírez, Ana S; Quadros, Edward V; Locher, Kaspar P.
Affiliation
  • Bloch JS; Institute of Molecular Biology and Biophysics, ETH Zürich, Zürich, Switzerland.
  • Sequeira JM; Department of Medicine, SUNY-Downstate Medical Center, Brooklyn, New York, USA.
  • Ramírez AS; Institute of Molecular Biology and Biophysics, ETH Zürich, Zürich, Switzerland.
  • Quadros EV; Department of Medicine, SUNY-Downstate Medical Center, Brooklyn, New York, USA.
  • Locher KP; Institute of Molecular Biology and Biophysics, ETH Zürich, Zürich, Switzerland.
FASEB J ; 36(4): e22222, 2022 04.
Article in En | MEDLINE | ID: mdl-35218573

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitamin B 12 / Transcobalamins / Receptors, Cell Surface / Immunoconjugates / Single-Domain Antibodies / Saporins / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2022 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitamin B 12 / Transcobalamins / Receptors, Cell Surface / Immunoconjugates / Single-Domain Antibodies / Saporins / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2022 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos